Churn and net portfolio loss reached multi-year lows, driven by operational improvements, new product launches, and a focus on core retail healthcare. Revenue dipped due to portfolio divestment, but cash generation and cost control remain strong.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.